HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: China Animal Testing; Oral-B Mobile App; Perfumista Ave.; More

This article was originally published in The Rose Sheet

Executive Summary

With China reviewing its cosmetics regulations, Cruelty Free International is optimistic that reforms to the country’s animal-testing requirements are on the horizon. More news in brief.

You may also be interested in...



Activists Celebrate India’s Expected Ban On Cosmetic Animal Testing

Reportedly, India’s Bureau of Indian Standards has revised its standard for cosmetic safety testing, effectively banning the use of animals to substantiate the safety of cosmetic products and ingredients, in harmony with the European Union. Meanwhile, EU Health Commissioner Tonio Borg reports “first signs of acceptance of alternative methods in China.”

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel